Search Results - "Spalek, Adrianna"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience by Spałek, Adrianna, Wieczorkiewicz-Kabut, Agata, Koclęga, Anna, Woźniczka, Krzysztof, Węglarz, Patryk, Boral, Kinga, Kata, Dariusz, Zielińska, Patrycja, Helbig, Grzegorz

    Published in International journal of hematology (01-12-2022)
    “…Steroid-refractory acute graft-versus-host disease (SR-aGVHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captopril by Mitręga, Katarzyna A, Spałek, Adrianna M, Nożyński, Jerzy, Porc, Maurycy, Stankiewicz, Magdalena, Krzemiński, Tadeusz F

    Published in PloS one (21-06-2017)
    “…During the last 25 years angiotensin-converting enzyme inhibitors spectacularly conquered the field of cardiovascular diseases therapy. Nevertheless, lack of…”
    Get full text
    Journal Article
  6. 6

    Room for Improvement: A 20-Year Single Center Experience with Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes by Duda, Katarzyna, Wieczorkiewicz-Kabut, Agata, Spałek, Adrianna, Koclęga, Anna, Kopińska, Anna J., Woźniczka, Krzysztof, Helbig, Grzegorz

    “…Allogeneic stem cell transplantation (allo-SCT) remains the only curative therapeutic approach for patients with myelodysplastic syndromes (MDS). The aim of…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Dihydropyridines’ metabolites-induced early apoptosis after myocardial infarction in rats; new outlook on preclinical study with M-2 and M-3 by Mitręga, Katarzyna A., Nożyński, Jerzy, Porc, Maurycy, Spałek, Adrianna M., Krzemiński, Tadeusz F.

    Published in Apoptosis (London) (01-02-2016)
    “…Our previous studies established cardio-protective effects of furnidipine and its active metabolites called M-2 and M-3. The aim of current research was to…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Allogeneic transplantation for high-risk chronic lymphocytic leukemia—a summary of a 16-year experience by Helbig, Grzegorz, Spałek, Adrianna, Wieczorkiewicz-Kabut, Agata, Markiewicz, Mirosław, Kopera, Małgorzata, Zielińska, Patrycja, Woźniczka, Krzysztof, Kopińska, Anna, Grygoruk-Wiśniowska, Iwona, Koclęga, Anna

    Published in Annals of hematology (01-06-2019)
    “…In the pathway inhibitor era, the number of allogeneic stem cell transplantation (ASCT) for chronic lymphocytic leukemia (CLL) continues to decrease and this…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20